Ma. Ostos et al., Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IVin apolipoprotein E-deficient mice, ART THROM V, 21(6), 2001, pp. 1023-1028
Mice expressing human apolipoprotein A-IV (apoA-IV) mainly in the intestine
were obtained in an apolipoprotein E-deficient (apoE(o)) background (apoA-
IV/E-o mice). Quantification of aortic lesions and plasma lipid determinati
on showed that compared with their control apoE(o) counterparts, the apoA-I
VIE, mice are protected against atherosclerosis without an increase in HDL
cholesterol, Because oxidized lipoproteins play an important role in athero
genesis, we tested whether the protection observed in these animals is acco
mpanied by an in vivo reduction of the oxidation parameters. The lag time i
n the formation of conjugated dienes during copper-mediated oxidation, the
aggregation state of LDL, and the presence of anti-oxidized LDL antibodies
were measured. The presence of oxidized proteins in tissues and the presenc
e of oxidation-specific epitopes in heart sections of atherosclerotic lesio
ns were also analyzed. Except for lag time, the results showed that the oxi
dation parameters were reduced in the apoA-IV/E-o mice compared with the ap
oE(o) mice. This suggests that human apoA-IV acts in vivo as an antioxidant
, In addition, human apoA-IV accumulation was detected in the atherosclerot
ic lesions of apoA-IV/E-o mice, suggesting that apoA-IV may inhibit oxidati
ve damage to local tissues, thus decreasing the progression of atherosclero
sis.